Literature DB >> 21222267

Applications of the role of α-MSH in ocular immune privilege.

Andrew W Taylor1, Darren Lee.   

Abstract

There is an important role for α-MSH and the melanocortin receptors in ocular immunity, development and health. This chapter will cover what is known about how α-MSH is part of the mechanisms of ocular immune privilege, about the expression of melanocortin receptors and the implications of these findings on the role of α-MSH in ocular physiology and its potential use to treat ocular pathologies.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21222267      PMCID： PMC3329275          DOI： 10.1007/978-1-4419-6354-3_12

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


  72 in total

1.  Neuropeptide alpha-MSH antagonizes IL-6- and TNF-induced fever.

Authors:  L W Martin; A Catania; M E Hiltz; J M Lipton
Journal:  Peptides       Date:  1991 Mar-Apr       Impact factor: 3.750

2.  Acute phase response to endotoxin: rise in plasma alpha-MSH and effects of alpha-MSH injection.

Authors:  L W Martin; J M Lipton
Journal:  Am J Physiol       Date:  1990-10

3.  A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.

Authors:  R R Caspi; F G Roberge; C C Chan; B Wiggert; G J Chader; L A Rozenszajn; Z Lando; R B Nussenblatt
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

4.  Modulation of IL-1, tumor necrosis factor, and C5a-mediated murine neutrophil migration by alpha-melanocyte-stimulating hormone.

Authors:  M J Mason; D Van Epps
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

5.  Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone.

Authors:  R A Star; N Rajora; J Huang; R C Stock; A Catania; J M Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

6.  Inhibition of IL-1 beta-induced peripheral inflammation by peripheral and central administration of analogs of the neuropeptide alpha-MSH.

Authors:  T Watanabe; M E Hiltz; A Catania; J M Lipton
Journal:  Brain Res Bull       Date:  1993       Impact factor: 4.077

7.  Alpha-MSH peptides inhibit acute inflammation induced in mice by rIL-1 beta, rIL-6, rTNF-alpha and endogenous pyrogen but not that caused by LTB4, PAF and rIL-8.

Authors:  M E Hiltz; A Catania; J M Lipton
Journal:  Cytokine       Date:  1992-07       Impact factor: 3.861

8.  Immune privilege and suppression of immunogenic inflammation in the anterior chamber of the eye.

Authors:  S W Cousins; W B Trattler; J W Streilein
Journal:  Curr Eye Res       Date:  1991-04       Impact factor: 2.424

9.  Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation.

Authors:  R D Granstein; R Staszewski; T L Knisely; E Zeira; R Nazareno; M Latina; D M Albert
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

10.  Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor.

Authors:  A W Taylor; J W Streilein; S W Cousins
Journal:  Curr Eye Res       Date:  1992-12       Impact factor: 2.424
View more
  17 in total

Review 1.  Tregs and infections: on the potential value of modifying their function.

Authors:  Sharvan Sehrawat; Barry T Rouse
Journal:  J Leukoc Biol       Date:  2011-09-13       Impact factor: 4.962

Review 2.  Intracellular signaling mechanisms of the melanocortin receptors: current state of the art.

Authors:  Adriana R Rodrigues; Henrique Almeida; Alexandra M Gouveia
Journal:  Cell Mol Life Sci       Date:  2014-12-12       Impact factor: 9.261

3.  Following EAU recovery there is an associated MC5r-dependent APC induction of regulatory immunity in the spleen.

Authors:  Darren J Lee; Andrew W Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-17       Impact factor: 4.799

Review 4.  Negative regulators that mediate ocular immune privilege.

Authors:  Andrew W Taylor; Tat Fong Ng
Journal:  J Leukoc Biol       Date:  2018-02-12       Impact factor: 4.962

Review 5.  The innate immune system in diabetic retinopathy.

Authors:  Warren W Pan; Feng Lin; Patrice E Fort
Journal:  Prog Retin Eye Res       Date:  2021-01-08       Impact factor: 19.704

6.  Adrenocorticotropic hormone gel in the treatment of systemic lupus erythematosus: A retrospective study of patients.

Authors:  Xiao Li; Josh Golubovsky; Joyce Hui-Yuen; Ummara Shah; Ewa Olech; Rosalia Lomeo; Vijay Singh; Howard Busch; Mary Jane Strandberg; Kayla Strandberg; Leslie Horowitz; Anca Askanase
Journal:  F1000Res       Date:  2015-10-23

Review 7.  Parainflammation, chronic inflammation, and age-related macular degeneration.

Authors:  Mei Chen; Heping Xu
Journal:  J Leukoc Biol       Date:  2015-08-20       Impact factor: 4.962

8.  α-Melanocyte-stimulating hormone protects retinal vascular endothelial cells from oxidative stress and apoptosis in a rat model of diabetes.

Authors:  Lijuan Zhang; Lijie Dong; Xun Liu; Yuanfeng Jiang; Lingjun Zhang; Xiaomin Zhang; Xiaorong Li; Yan Zhang
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

Review 9.  Targeting the complement system for the management of retinal inflammatory and degenerative diseases.

Authors:  Heping Xu; Mei Chen
Journal:  Eur J Pharmacol       Date:  2016-03-03       Impact factor: 4.432

10.  Activation of Melanocortin Receptors MC 1 and MC 5 Attenuates Retinal Damage in Experimental Diabetic Retinopathy.

Authors:  S Rossi; R Maisto; C Gesualdo; M C Trotta; F Ferraraccio; M K Kaneva; S J Getting; E Surace; F Testa; F Simonelli; P Grieco; F Merlino; M Perretti; M D'Amico; C Di Filippo
Journal:  Mediators Inflamm       Date:  2016-01-12       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.